AXL and non-small cell lung carcinoma: Furthermore, Jung et al. [80] demonstrated that carvacrol can inhibit cell proliferation and migration in non-small cell lung cancer (NSCLC) by down-regulating tyrosine kinase receptor (AXL) expression and inhibiting the phosphorylation of AXL upon ligand stimulation.